Insurance Denial Appeal Letters as Expert Evidence in PI Cases
Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 8 min read
The appeal letter a prescriber writes to overturn an insurance denial contains detailed clinical reasoning that functions as an expert statement on medical necessity. Learn how these letters serve as powerful evidence in PI litigation.
An insurance denial appeal letter written by the treating prescriber is one of the most underutilized pieces of expert evidence in personal injury litigation. When an insurance company denies coverage for a medication and the prescriber submits a clinical appeal, that appeal letter contains a detailed, contemporaneous statement explaining why the medication is medically necessary for the specific patient, what alternatives have been tried and failed, and why the denied medication is clinically superior to the alternatives. This letter, written in the ordinary course of patient care rather than in anticipation of litigation, carries the credibility of a treating physician's expert opinion without the adversarial context that taints retained expert reports.
- Insurance denial appeal letters contain the prescriber's detailed clinical reasoning for why a specific medication is medically necessary for the patient
- These letters are written during the ordinary course of patient care, not for litigation purposes, giving them enhanced credibility
- LienScripts documents every insurance interaction in the medication history, and each case receives a MERIT (Medication Evaluation & Rationale for Injury Treatment) report that incorporates appeal letter findings when available
- Appeal letters typically include treatment failure history, clinical rationale, and peer-reviewed literature references -- the same elements found in formal expert reports
- The prescriber wrote the letter to convince an insurance company that has financial incentives to deny coverage -- if the clinical case was strong enough to overcome that bias, it is strong enough for litigation
Anatomy of an Appeal Letter
A clinical appeal letter typically includes:
Patient-Specific Clinical History
The prescriber describes the patient's diagnosis, the injury mechanism, the duration and severity of symptoms, and the treatment course to date. This is a contemporaneous clinical summary written by the treating physician.
Treatment Failure Documentation
The letter documents which medications were tried and failed, including:
- The specific medication tried
- The dose and duration of the trial
- The reason for failure (inadequate efficacy, adverse effects, contraindication)
- The clinical evidence that the trial was adequate before being deemed a failure
Medical Necessity Argument
The prescriber explains why the denied medication is medically necessary for this specific patient, including:
- Why alternative medications are not appropriate
- How the denied medication addresses the patient's specific clinical needs
- What clinical outcomes are expected from the denied medication
Literature and Guideline References
Many appeal letters cite peer-reviewed clinical literature, clinical practice guidelines, and professional organization recommendations supporting the medication's use for the patient's condition.
As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "An appeal letter is essentially an expert report that the treating physician wrote before anyone thought about litigation. It contains the diagnosis, the treatment history, the clinical reasoning, and often the literature citations. The difference is that the physician wrote it to convince a skeptical insurance reviewer who has every financial reason to say no. If the clinical argument was compelling enough to overturn an insurance denial, it is compelling enough for any trier of fact."
Why Appeal Letters Carry Greater Weight Than Retained Expert Reports
Written in the Ordinary Course of Care
Appeal letters are generated as part of routine clinical practice when insurance barriers prevent medication access. They are not produced for litigation and are not influenced by the adversarial posture of the case. This contemporaneous, non-litigation origin enhances their credibility.
Written to Overcome Financial Bias
The audience for an appeal letter is an insurance reviewer whose organization profits by denying coverage. The prescriber must make a clinical case compelling enough to overcome this institutional bias. The evidentiary bar is arguably higher than the standard needed to persuade a jury.
Authored by the Treating Prescriber
The letter is written by the physician who actually examined and treated the patient, not by a retained expert who reviewed records from a distance. Treating physician opinions carry greater weight in most jurisdictions because they are based on direct clinical observation.
Contemporaneous Documentation
The letter is dated and reflects the prescriber's clinical assessment at the time the denial occurred. It is not a retrospective reconstruction of the treatment rationale -- it is a real-time clinical argument.
How to Obtain and Use Appeal Letters
Obtaining the Letters
Appeal letters are part of the patient's medical record and can be obtained through:
- Medical records request -- the prescriber's office maintains copies of all correspondence
- Insurance company records -- the insurance company's claim file contains the appeal and the response
- Pharmacy records -- LienScripts tracks all insurance interactions and can identify when appeals were submitted
Using Appeal Letters in Demand Packages
When incorporating appeal letter evidence into demand packages:
- Include the full appeal letter -- present the prescriber's complete clinical argument
- Highlight the medical necessity section -- extract the prescriber's specific statement of medical necessity
- Emphasize treatment failure history -- show the documented pathway of failed alternatives
- Note the outcome -- if the appeal was approved, the insurance company's own reviewers agreed with the prescriber's clinical reasoning
- If the appeal was denied -- a denied appeal still contains the prescriber's expert clinical opinion, and the denial itself documents the insurance barrier that affected treatment access
LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages that integrates appeal findings when available.
Appeal Approval as Third-Party Validation
When the insurance company overturns the denial and approves the medication, the approval constitutes third-party validation of the prescriber's medical necessity argument. The insurance company's own clinical reviewers:
- Read the prescriber's clinical reasoning
- Reviewed the patient's treatment history
- Applied their own medical necessity criteria
- Determined the medication is clinically appropriate
This approval is independent validation from an entity with financial incentives to deny coverage -- making it exceptionally powerful evidence of medical necessity.
Countering Defense Arguments
"The appeal letter is self-serving."
The letter was written to an insurance company during routine patient care, not for litigation. It predates any litigation context and was motivated by the clinical need to secure medication access for the patient, not by case strategy.
"The prescriber was just advocating for the patient."
Prescribers do advocate for patients through appeal letters, and that advocacy is based on their clinical judgment. The appeal letter documents that clinical judgment in detail, with the specific reasoning and evidence that support it. Advocacy informed by clinical expertise is exactly what expert opinions are.
"The insurance company denied the medication, so it must not be necessary."
Insurance denials are frequently based on formulary management criteria (step therapy, preferred alternatives) rather than clinical necessity. The appeal process exists specifically because initial denials often do not account for patient-specific clinical factors. If the appeal was approved, the insurance company itself agreed the initial denial was incorrect.
Practical Takeaways
Insurance denial appeal letters are pre-made expert evidence hiding in the patient's medical file. They contain detailed clinical reasoning, treatment failure documentation, medical necessity arguments, and often literature citations -- all written by the treating prescriber in the ordinary course of care. Attorneys who obtain and present appeal letters add a layer of expert evidence that carries enhanced credibility because it was never created for litigation purposes.
Related Resources
- Prior Authorization Denials as Severity Evidence -- How denial processes document severity
- Clinical Practice Guideline Adherence as Standard of Care -- Using guidelines to validate treatment
- Medication Switches Prove Treatment Failure -- Documenting medication failures
Frequently Asked Questions
Why are insurance appeal letters valuable as evidence?
Appeal letters contain detailed clinical reasoning -- diagnosis, treatment failure history, medical necessity arguments, and often literature citations -- all written by the treating prescriber in the ordinary course of care. Because they were written to convince an insurance reviewer rather than for litigation, they carry enhanced credibility as contemporaneous expert opinions.
How are appeal letters different from retained expert reports?
Appeal letters are written by the treating prescriber in the ordinary course of patient care, not by a retained expert hired for litigation. They are contemporaneous (written at the time of the clinical decision), directed at a financially motivated skeptic (the insurance reviewer), and based on direct patient examination rather than record review.
Does it matter whether the insurance appeal was approved or denied?
Both outcomes are useful. An approved appeal means the insurance company's own reviewers validated the prescriber's medical necessity argument -- powerful third-party evidence. A denied appeal still contains the prescriber's detailed clinical opinion, and the denial itself documents the insurance barrier that affected treatment access.